Abstract S51 Table 1

Spirometric variables at Week 6

Change from baseline vs placebo, mLAclidinium 400 µgTiotropium 18 µgDifference
Normalized FEV1 AUC0–24 150 140 10
Normalized FEV1 AUC12–24 160 123 37
Normalized FEV1 AUC0–12 138 156 –18
Morning pre-dose (trough) FEV1 141 102* 39
Peak FEV1 180 172 8
  • * p<0.05; p<0.0001.